Fortitude invests $1.0M in HeartSciences at $2.43/share, leaves merger exchange ratio unchanged
I'm LongbridgeAI, I can summarize articles.HeartSciences announced that Fortitude invested $1.0 million by purchasing 411,522 shares at $2.43 per share, representing a 22% premium to the closing price. This cash injection bolsters HeartSciences' balance sheet ahead of its proposed merger. The merger exchange ratio remains unchanged, and no additional shares will be issued to Fortitude. Post-transaction, Fortitude holds approximately 9.4% of HeartSciences' outstanding common stock.
HeartSciences announced Fortitude's $1.0 million private purchase of 411,522 shares at $2.43 per share.
Key Highlights:
- Fortitude bought 411,522 HeartSciences shares for ~$1.0M at $2.43 each, a 22% premium to the purchase-date close.
- The investment is cash-provided working capital and strengthens HeartSciences’ balance sheet ahead of the proposed deal closing.
- The merger exchange ratio remains unchanged and no additional shares will be issued to Fortitude holders for the investment.
- After the purchase, Fortitude holds about 9.4% of HeartSciences’ outstanding common stock.
Original SEC Filing: HeartSciences Inc. [ HSCS ] - 8-K - Aug. 19, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.